Company intelligence / Profile preview
Lahjavida, Inc.
Colorado Springs, Colorado, United Stateslahjavida.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Lahjavida has developed proprietary technology that combines tumor-targeting dyes with chemotherapy drugs, showing promise in selectively eliminating cancer cells. The company is seeking funding to demonstrate compound accumulation in tumors and radiowave treatment efficacy in animal models.
- Therapeutic areas
- Oncology
- Modalities
- Dye Drug Conjugates (DDCs)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
University of Colorado, Colorado SpringsDr. Anatoliy Pinchuk's laboratory
Beyond the preview
Go deeper on Lahjavida, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lahjavida, Inc..